|

UnitedHealth stock sinks below $380 for first time in four years

  • UNH stock sinks for the fourth day in a row.
  • Dow Jones Industrial Average pulls back ahead of the weekend.
  • Part of the stock market is optimistic for this weekend's trade meeting between China and the US.
  • UnitedHealth stock has been trending lower since lowering full-year guidance.

UnitedHealth Group (UNH) stock traded lower on Friday, sinking to four-year lows below $379. Shares of the US' largest health insurer moved steadily lower in the session for the fourth straight session. UNH stock has traded lower for 12 out of the last 16 sessions following its April 17 earnings release in which management cut full-year earnings guidance by ~12%.

The downward pressure on UNH shares over recent weeks has contrasted sharply with optimism in the overall broad market. But on Friday, the two are aligned. The Dow Jones Industrial Average (DJIA), which includes UnitedHealth as one of its largest weightings, has moved moderately lower as UNH shaves off another 1.7%.

The stock market is generally hopeful for a breakthrough at trade talks between the US and China this weekend, and President Donald Trump told reporters he might lower tariffs on Chinese goods from 145% to 80% as a sign of good will.

UnitedHealth Group stock news

The drastic 37% sell-off that has impressed traders with its momentum is largely a product of management cutting its full-year guidance for adjusted earnings per share (EPS) from the $29.50 to $30.00 range to $26.00 to $26.50. That circa 12% revision was all it took for a large swath of shareholders to exit their positions.

It doesn't seem to matter to the market that the issue at hand is higher medical utilization. The medical care ratio rose from 84.3% last year to 84.8% in the first quarter. The trend was due to a higher mix of seniors on insurance plans and changes to Medicare payment terms, but the management called the issue seasonal in nature.

"We are aggressively addressing those challenges to position us well for the years ahead and return to our long-term earnings growth rate target of 13% to 16%,” said Andrew Witty, chief executive officer of UnitedHealth Group, in a statement in April.

On Wednesday, a group of shareholders sued the company for allegedly hiding how public backlash to the killing of UnitedHealthcare CEO Brian Thompson had pushed the company to change its business practices. The suit filed in Manhattan court alleges that UnitedHealth altered its policy that had previously led to higher claim denials without sharing these details with shareholders.

UnitedHealth Group stock forecast

As UNH stock decisively sank below $380 on Friday, as well as below the 100% Fibonacci Extension placeholder at $384.51, potential bulls are asking themselves where to enter this trade. After all, this is the insurance industry, and UnitedHealth Group has been one of the most dependable dividend growth stocks for some time.

What's more, UNH stock tends to favor V-shaped recoveries after sell-offs. This happened in April 2024, December 2024, and again in February of this year. So quick reversals are what bulls have come to respect.

There is some historical support in the mid-$360s from early 2021, but more bearish observers might hope that UNH sails down to the 161.8% Fibo at $313.19. Others will find that unlikely, as that level is so far below the current price dynamic.

UNH daily stock chart

UNH daily stock chart

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Clay Webster

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

More from Clay Webster
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD eyes 1.1800 barrier near two-month highs

EUR/USD extends its gains for the second consecutive day on Tuesday and approaches 1.1800. On the daily chart, technical analysis indicates a persistent bullish bias, as the pair moves upward within the ascending channel pattern. Additionally, the 14-day Relative Strength Index at 68.89 reaffirms the bullish bias.

GBP/USD climbs to 1.3500 area, renews ten-week high

GBP/USD extends its weekly rally and trades at its highest level since early October near 1.3500. The US Dollar remains under persistent bearish pressure heading into the holidays, while Pound traders largely brush off the latest interest rate cut from the Bank of England.

Gold approaches $4,500 as record-setting rally continues

Gold builds on Monday's impressive gains and advances toward $4,500, setting fresh record-highs along the way. Heightened geopolitical tensions, combined with the broad-based US Dollar (USD) weakness ahead of the Q3 GDP data, help XAU/USD preserve its bullish momentum.

US GDP expected to highlight steady growth in Q3

The United States Bureau of Economic Analysis (BEA) will publish the first preliminary estimate of the third-quarter Gross Domestic Product on Tuesday, at 13:30 GMT. Analysts expect the data to show annualized growth of 3.2%, following the 3.8% expansion in the previous quarter.

Ten questions that matter going into 2026

2026 may be less about a neat “base case” and more about a regime shift—the market can reprice what matters most (growth, inflation, fiscal, geopolitics, concentration). The biggest trap is false comfort: the same trades can look defensive… right up until they become crowded.

XRP steadies above $1.90 support as fund inflows and retail demand rise

Ripple (XRP) is stable above support at $1.90 at the time of writing on Monday, after several attempts to break above the $2.00 hurdle failed to materialize last week. Meanwhile, institutional interest in the cross-border remittance token has remained steady.